Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Chaffoy de Courcelles

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Receptor Research|January 1, 1987
Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockadeJ E Leysen, P Van Gompel, D de Chaffoy de Courcelles, et al.
Thrombosis and Haemostasis|October 28, 1987
The effect of the intracellular calcium chelator Quin-2 on the platelet phosphoinositide metabolism, protein phosphorylation and morphologyD de Chaffoy de Courcelles, P Roevens, F Verheyen, et al.
The Journal of Biological Chemistry|February 25, 1989
The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949D de Chaffoy de Courcelles, P Roevens, H Van Belle, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biochemical profile of risperidone, a new antipsychoticJ E Leysen, W Gommeren, A Eens, et al.
The Journal of Biological Chemistry|June 25, 1985
Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sitesD de Chaffoy de Courcelles, J E Leysen, F De Clerck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1992
Cardiac effects of R 79595 and its isomers (R 80122 and R 80123) in an acute heart failure model. A new class of cardiotonic agents with highly selective phosphodiesterase III inhibitory propertiesJ Schneider, E Beck, C Heers, et al.
Neuropharmacology|December 1, 1984
Serotonin-S2 receptor binding sites and functional correlatesJ E Leysen, D de Chaffoy de Courcelles, F De Clerck, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1992
Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogsA Van de Water, J d'Aubioul, W Van Gerven, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Receptor Research|January 1, 1987
Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockadeJ E Leysen, P Van Gompel, D de Chaffoy de Courcelles, et al.
Thrombosis and Haemostasis|October 28, 1987
The effect of the intracellular calcium chelator Quin-2 on the platelet phosphoinositide metabolism, protein phosphorylation and morphologyD de Chaffoy de Courcelles, P Roevens, F Verheyen, et al.
The Journal of Biological Chemistry|February 25, 1989
The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949D de Chaffoy de Courcelles, P Roevens, H Van Belle, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biochemical profile of risperidone, a new antipsychoticJ E Leysen, W Gommeren, A Eens, et al.
The Journal of Biological Chemistry|June 25, 1985
Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sitesD de Chaffoy de Courcelles, J E Leysen, F De Clerck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1992
Cardiac effects of R 79595 and its isomers (R 80122 and R 80123) in an acute heart failure model. A new class of cardiotonic agents with highly selective phosphodiesterase III inhibitory propertiesJ Schneider, E Beck, C Heers, et al.
Neuropharmacology|December 1, 1984
Serotonin-S2 receptor binding sites and functional correlatesJ E Leysen, D de Chaffoy de Courcelles, F De Clerck, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1992
Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogsA Van de Water, J d'Aubioul, W Van Gerven, et al.
Pageof 3